9
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T37577 | Glycogen Phosphorylase Inhibitor | ||
Glycogen phosphorylase in the liver, muscle, and brain initiate glycogenolysis by releasing glucose-1-phosphate from glycogen. Glycogen phosphorylase inhibitor is a cell-permeable acyl urea first identified as an inhibit... | |||
T8493 | Ingliforib | GPi 296,CP 368296 | Phosphorylase |
Ingliforib (CP 368296) is a novel glycogen phosphorylase inhibitor,has antihyperglycemic and cardioprotective properties. | |||
T22683 | CP-316819 | CP 316819,GPi 819 | Others |
CP-316819 (GPi 819) is a potent inhibitor of glycogen phosphorylase (GPase) with hypoglycemic effects, inhibits huSMGPa and huLGPa, maintains neuronal activity during hypoglycemia, and can be used in the study of hypergl... | |||
T10421 | AVE5688 | Phosphorylase | |
AVE5688 is an inhibitor of glycogen phosphorylase (GP, IC50s: 430 nM and 915 nM; Kds: 170 nM and 530 nM for rmGPb and rmGPa). It can be used for the research of type 2 diabetes. | |||
T6455 | CP-91149 | Phosphorylase | |
CP-91149 is a selective glycogen phosphorylase (GP) inhibitor with IC50 of 0.13 μM in the presence of glucose, 5- to 10-fold less potent in the absence of glucose. | |||
T22803 | GPi 688 | Others | |
glycogen phosphorylase inhibitor | |||
T68524 | AVE 9423 | ||
AVE 9423 is an allosteric glycogen phosphorylase inhibitor. | |||
T31048 | CP-320626 | CP 320626 | |
CP-320626 is an effective inhibitor of glycogen phosphorylase A (LGPA) in the human liver and GPA in the human muscle. Can act synergistically with glucose. It is a possible target for the treatment of type 2 diabetes. | |||
TN4584 | Morolic acid | IL Receptor , COX , HIV Protease | |
Morolic acid and moronic acid have shown sustained antidiabetic and antihyperglycemic action possibly mediated by an insulin sensitization with consequent changes of glucose, cholesterol and triglycerides, in part mediat... |